AbbVie Lifts Long-Term Outlook For New Immunology Drugs, Even As Q4 Revenue and Profit Fall
AbbVie reports Q4 earnings with adjusted EPS at $2.79, beating consensus. Sees FY 2024 EPS of $11.05-$11.25. Raises 2027 outlook for key products.
Why Is Sanofi Partner Regeneron Pharmaceuticals Stock Trading Higher Today?
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported fourth-quarter adjusted EPS of $11.86, down 6% Y/Y, beating the consensus of $10.77.
Rivian Faces Technical Headwinds As Death Cross Looms In Stock Chart
Rivian's stock faces challenges as it navigates a competitive EV market and a potential death cross on the stock chart, signaling possible declines.
What’s Going On With US Pharma Giant Bristol-Myers Squibb Stock Today?
Bristol Myers Squibb reports Q4 revenues of $11.48 billion, up 1% YoY. Eliquis and Opdivo sales drive growth, offsetting Revlimid decline.
Exxon’s Q4 Surprise: Beats Earnings Expectations Despite Revenue Dip, Embarks On Bold EV And LNG Ventures
Exxon Mobil (XOM) reported Q4 FY23 adjusted net profit of $9.96 billion, or $2.48 per share, beating consensus estimates. Improved profits result from favorable derivative impacts, increased volume on key assets.
Tech Giants Transform: From FAANG To Magnificent 7, Now Entering The AI5 Era
In recent years, the FAANG era of tech dominance has given way to the rise of Mag7 and now the AI5 - Microsoft, TSMC, Broadcom, Nvidia, and AMD - shaping the market with their cutting-edge AI technology.
US Economy Adds 353,000 Payrolls In January: Monster Job Growth Well Above Expectations, Destroys Fed Rate Cut Bets
US labor market surprises with strong January jobs report, including significant wage growth.
Why Is Health Insurance Plan Provider Cigna Stock Trading Higher Today?
Cigna's robust Q4 2023 performance with $51.15 billion in sales, up 12% Y/Y. Dive into the growth of Cigna Healthcare, Evernorth Health Services.
Oil Major Chevron’s Mixed Q4 Results: US Upstream Loss, Dividend Boost & More
Chevron Corporation (CVX) posts Q4 FY23 results with total revenues at $47.18 billion, slightly below the expected $51.62 billion consensus. Despite the revenue miss, the company reports 4% increase in worldwide net oil-equivalent production, driven by strategic acquisitions and Permian Basin growth. Adjusted net earnings at $6.45 billion beat estimates at $3.45 per share. Chevron demonstrates shareholder commitment with an 8% dividend increase, and shares respond positively.
BP Shuts Whiting Refinery Due To Transformer Failure, Sparks Fuel Supply Fears: Report
BP's Whiting refinery reportedly evacuated after transformer failure caused a power outage. There were no details on how long BP would take to restart the refinery.